Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: DrugBank:EXPT01586 (
G418
)
2,237
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The full length cDNA of rat alkaline phosphatase (AP) was placed under the control of the SV40 early promoter. This plasmid was transfected by the calcium phosphate method into AP negative
ROS
25/1 cells. Ten clones with AP specific activities ranging between 0.1-2 mumole/min/mg were isolated by cotransfection with the plasmid pSV2Neo, which renders the cells resistant to the antibiotic
G418
. Two clones with different AP specific activities: C (0.01 mumole/min/mg) and S (2.0 mumole/min/mg) and the osteoblastic
ROS
17/2.8 cells (2.0 mumole/min/mg), were examined for their ability to mineralize. In vitro mineralization was tested by culturing cells in alpha-MEM containing 10% fetal bovine serum and 50 micrograms/ml ascorbate in the presence or absence of 10 mM beta-glycerophosphate. Mineralized deposits were observed in all cultures of the S clone and
ROS
17/2.8 cells in the presence of beta-glycerophosphate, but not in C clones. Measurement of calcium and phosphorus levels in cells correlated with AP levels of transfected cells. However, extent of mineral accumulation in the transfected
ROS
25/1 cells differ from the osteogenic
ROS
17/2.8 cells. This finding indicates that high levels of AP may be a necessary constituent for the mineralization process together with other factors yet to be identified.
...
PMID:Alkaline phosphatase cDNA transfected cells promote calcium and phosphate deposition. 259 68